2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
End-of-Life Care: Hospice care, ethical issues, and patient-family communication.
End-of-life care in cancer treatment involves providing compassionate, patient-centered support during the final stages of a person’s life. Hospice care plays a pivotal role in this process, focusing on pain management, comfort, and emotional support rather than curative treatment. Ethical issues surrounding end-of-life decisions often arise, including topics such as advanced directives, the right to die, and palliative sedation. Open and honest communication between healthcare providers, patients, and their families is essential in making these decisions, ensuring that the patient's wishes are respected while providing emotional and spiritual support. This stage also highlights the importance of preparing family members for the emotional challenges they will face. End-of-life care not only seeks to ease physical suffering but also aims to offer patients dignity, allowing them to pass peacefully, surrounded by loved ones, with a sense of control over their final days.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China